ECO 2026: Oral Orforglipron Maintains Weight Loss After GLP-1 Switch Tags GLP-1 agonists Read more about ECO 2026: Oral Orforglipron Maintains Weight Loss After GLP-1 Switch
ECO 2026: EASO Updates Obesity Drug Guidance Algorithm Tags GLP-1 agonists Read more about ECO 2026: EASO Updates Obesity Drug Guidance Algorithm
Estimated Oral Semaglutide Exposure Linked to Weight Loss and GI Side Effects Tags GLP-1 agonists Read more about Estimated Oral Semaglutide Exposure Linked to Weight Loss and GI Side Effects
GLP-1 RAs Linked to Lower Mortality in Breast Cancer Tags GLP-1 agonists Read more about GLP-1 RAs Linked to Lower Mortality in Breast Cancer
Dapagliflozin-Linagliptin Combination Improved TIR in T2DM Tags DPP-4 inhibitors SGLT-2 Inhibitor Read more about Dapagliflozin-Linagliptin Combination Improved TIR in T2DM
MACE Rates With Semaglutide Were Similar Across Weight Loss Strata Tags GLP-1 agonists Read more about MACE Rates With Semaglutide Were Similar Across Weight Loss Strata
GLP-1 Therapy Lowered MACE and Hypoglycemia Risk in T1DM Tags Coronary artery disease Myocardial infarction GLP-1 agonists Read more about GLP-1 Therapy Lowered MACE and Hypoglycemia Risk in T1DM
GLP-1 RAs in T1DM Show No Increased Severe Hypoglycemia or DKA Tags Diabetic ketoacidosis Hypoglycemia GLP-1 agonists Read more about GLP-1 RAs in T1DM Show No Increased Severe Hypoglycemia or DKA
AACE 2026: Tirzepatide Improves Quality of Life Than Dulaglutide in T2DM-ASCVD Tags Coronary artery disease GLP-1 agonists Read more about AACE 2026: Tirzepatide Improves Quality of Life Than Dulaglutide in T2DM-ASCVD
AACE 26: Synthetic Semaglutide Delivers Similar HbA1c, Weight Outcomes in T2DM Tags GLP-1 agonists PLBS hBA1c Read more about AACE 26: Synthetic Semaglutide Delivers Similar HbA1c, Weight Outcomes in T2DM